Почетна › Колоректален карцином › Вирџинија › Arlington
Клинички испитувања за Колоректален карцином во Arlington, VA
52 студии за Колоректален карцином бараат учесници на локации во и околу Arlington (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
The Vanguard Study: Testing a New Way to Screen for Cancer
Се регрутираДобредојдени се здрави волонтери
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- Inova Fair Oaks Hospital, Fairfax · на 11 милји
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- NEXT Virginia, Fairfax · на 11 милји
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Се регрутираФаза 1/2
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- Virginia Cancer Specialists, PC, Fairfax · на 11 милји
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Се регрутираФаза 1
- ALX Center 2, Fairfax · на 11 милји
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Се регрутираФаза 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · на 11 милји
- Virginia Cancer Specialists, PC, Reston · на 14 милји
- и уште 1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
Се регрутираФаза 1/2
- NEXT Oncology, Fairfax · на 11 милји
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · на 11 милји
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Се регрутираФаза 3
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Се регрутираФаза 3
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · на 11 милји
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Се регрутираФаза 2/3
- Local Institution - 0278, Fairfax · на 11 милји
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Се регрутираФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · на 11 милји
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Се регрутираФаза 1
- NEXT - Virginia, Fairfax · на 11 милји
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Oncology, Fairfax · на 11 милји
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Се регрутираФаза 3
- Clinical Study Site, Fairfax · на 11 милји
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
Се регрутираФаза 2
- Inova Schar Cancer, Fairfax · на 11 милји
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Се регрутираФаза 1
- NEXT Oncology, Fairfax · на 11 милји
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Clinical Trial Site, Fairfax · на 11 милји
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Next Virginia, Fairfax · на 11 милји
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Се регрутираФаза 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · на 11 милји
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · на 11 милји
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Се регрутираФаза 1
- NEXT Texas LLC - Virginia, Fairfax · на 11 милји
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Се регрутираФаза 1
- Research Site, Fairfax · на 11 милји
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Се регрутираФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 милји
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Се регрутираФаза 1/2
- Next Oncology Virginia, Fairfax · на 11 милји
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Се регрутираФаза 1
- NEXT Virginia, LLC, Fairfax · на 11 милји
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- NEXT Virginia, Fairfax · на 11 милји
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Се регрутираФаза 1/2
- NEXT, Virginia, Fairfax · на 11 милји
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · на 11 милји
Испитувања за Колоректален карцином во други градови
- Houston, TX102 студии
- New York City, NY78 студии
- Nashville, TN69 студии
- Boston, MA63 студии
- Los Angeles, CA59 студии
- St. Louis, MO50 студии
- San Antonio, TX46 студии
- Philadelphia, PA44 студии
- Grand Rapids, MI40 студии
- Baldwin Park, CA37 студии
- Chicago, IL34 студии
- Tampa, FL34 студии
Други студии во Arlington
- Рак на бели дробови со не-мали клетки104 студии
- Метастатски карцином53 студии
- Рак (сите типови)48 студии
- Рак на дојка47 студии
- Карцином на јајниците46 студии
- Рак на бели дробови41 студија
- Рак на ендометриумот39 студии
- Карцином на панкреасот33 студии
- Сквамозноклеточен карцином на глава и врат26 студии
- Малоклеточен рак на бели дробови23 студии
- Рак на стомакот20 студии
- Трипл негативен рак на дојка20 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.